News
ImmunityBio bags elusive label extension for Anktiva
The FDA has handed ImmunityBio a key label extension for bladder cancer therapy Anktiva, giving it a leg-up on rival drug Inlexzo from J&J.
News
Roche breast cancer drug Itovebi turned down by NICE
NICE turns down NHS use of Roche's breast cancer drug Itovebi, which the company says reveals a flaw in the appraisal of combination therapies.
News
MHRA lays out its thinking on AI and medicines regulation
An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
Market Access
UK’s next pricing and access scheme to last for 7 years
Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.
Market Access
One year after MFN: How US policy is reshaping the global ph...
Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
